Multicentric Castleman Disease (MCD)
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Multicentric Castleman Disease (MCD)

View Main Condition: Castleman Disease

What is the definition of Multicentric Castleman Disease (MCD)?
Multicentric Castleman Disease (MCD) is a rare disease that affects the lymph nodes and related tissues. It is a form of Castleman disease that is "systemic" and involves multiple regions of lymph nodes (as opposed to unicentric Castleman disease, which involves a single lymph node or single region of lymph nodes). The signs and symptoms of MCD are often nonspecific, and are mild in some people but serious in others. Symptoms may include enlarged lymph nodes in multiple regions, fever, weight loss, nausea, rash, and/or an enlarged large liver and spleen. The disease is diagnosed based on the symptoms present, laboratory test results, imaging studies, and results of a biopsy of the lymph nodes which shows specific features when studied under the microscope. In some cases, MCD is caused by human herpesvirus-8 (HHV-8) and is referred to as HHV-8-associated MCD. In other cases, the cause is not known and it is referred to as HHV-8 negative MCD, or idiopathic MCD (iMCD).
What are the alternative names for Multicentric Castleman Disease (MCD)?
  • Multicentric Castleman Disease
  • Idiopathic multicentric Castleman's disease
  • MCD
  • Multicentric giant lymph node hyperplasia
  • Multicentric plasma cell variant of Castleman's disease
  • PMCD
  • Plasmablastic multicentric Castleman disease
Who are the top Multicentric Castleman Disease (MCD) Local Doctors?
Elite in Multicentric Castleman Disease (MCD)
Hematology | Oncology
Elite in Multicentric Castleman Disease (MCD)
Hematology | Oncology
Referral may be required

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
Languages Spoken:
English, Bengali, Hindi
Accepting New Patients
Offers Telehealth

Sudipto Mukherjee is a Hematologist and an Oncologist practicing medicine in Cleveland, Ohio. Dr. Mukherjee is rated as an Elite provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Multicentric Castleman Disease (MCD), Castleman Disease, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Mukherjee is board certified in American Board Of Internal Medicine, 2019. Dr. Mukherjee is currently accepting new patients.

Elite in Multicentric Castleman Disease (MCD)
Elite in Multicentric Castleman Disease (MCD)
Referral may be required
Paris, FR 

Eric Oksenhendler practices practicing medicine in Paris, France. Mr. Oksenhendler is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, Unicentric Castleman Disease (UCD), and Splenectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Multicentric Castleman Disease (MCD)
Elite in Multicentric Castleman Disease (MCD)
Referral may be required
Université Paris Est, 
Creteil, FR 

Lionel Galicier practices practicing medicine in Creteil, France. Mr. Galicier is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Castleman Disease, Multicentric Castleman Disease (MCD), Thrombocytopenia, Splenectomy, and Bone Marrow Aspiration.

What are the latest Multicentric Castleman Disease (MCD) Clinical Trials?
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Summary: Persons living with HIV (PLWH) in sub-Saharan Africa (SSA), lymphadenopathy often portends one of a number of life-threatening diseases including tuberculosis, lymphoma, and multicentric Castleman disease (MCD). Overcoming these delays and missed diagnoses requires new approaches to identify lymphoma and MCD.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Background: Primary effusion lymphoma (PEL), plasmablastic lymphoma (PBL), and Multicentric Castleman Disease (MCD) are aggressive forms of cancer that affects cells in the immune system and lymph nodes. How they develop is not well understood, and these diseases do not respond well to standard treatments for other types of lymphomas.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are some Advocacy Organizations?
castleman-disease

The Castleman Disease Collaborative Network (CDCN) is a global initiative dedicated to accelerating research and treatment for Castleman disease and revolutionizing biomedical research.